The role of the Notch signaling pathway in liver fibrogenesis.

Authors

  • E. I. Lebedeva Vitebsk State Medical University, Vitebsk, Republic of Belarus., Belarus

DOI:

https://doi.org/10.26641/1997-9665.2020.1.7-15

Keywords:

Notch signaling pathway, liver fibrosis, stellate cells, macrophages, sinusoidal endothelial cells

Abstract

At the present stage, the subject of intensive research is the study of the transmission mechanisms of molecular signals of the conserved Notch signaling pathway in the development of liver pathologies. The review article summarizes current scientific evidence on the role of the signaling pathway in liver fibrogenesis. Literature analysis indicates that the role of the Notch signaling pathway in the regulation of stellate cells and hepatocytes activation, macrophage polarization and its interaction with other signaling pathways in fibrogenesis has not been fully studied. It should be noted that the study of changes in the activity of the signaling cascade is of great therapeutic importance in the development of a medical guidelines for fibrosis using new antifibrotic medications.

References

  1. Zhan Z, Chen Y, Duan Y, Li L, Mew K, Hu P, Ren H, Peng M. Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis. Peer J. 2019;7:e6645. doi: 10.7717/peerj.6645
  2. Tao Y, Tian K, Chen J, Tan D, Liu Y, Xiong Y, Chen Z, Tian Y. Network pharmacology-based prediction of the active compounds, potential targets, and signaling pathways involved in danshiliuhao granule for treatment of liver fibrosis. Evid Based Complement Alternat. Med. 2019;2630357. doi: 10.1155/2019/2630357
  3. Adams JM, Jafar-Nejad H. The Roles of Notch signaling in liver development and disease. Biomolecules. 2019;9(10). pii: E608. doi: 10.3390/biom9100608
  4. Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J. Hepatol. 2014;60(4):885-90. doi: 10.1016/j.jhep.2013.11.028
  5. Siebel C, Lendahl U. Notch signaling in development, tissue homeostasis, and disease. Physiol. Rev. 2017;97(4):1235-94. doi: 10.1152/physrev.00005.2017
  6. Wang J, Dong M, Xu Z, Song X, Zhang S, Qiao Y, Che L, Gordan J, Hu K, Liu Y, Calvisi DF, Chen X. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Oncogene. 2018;37(24):3229-42. doi: 10.1038/s41388-018-0188-1
  7. Chillakuri CR, Sheppard D, Lea SM, Handford PA. Notch receptor-ligand binding and activation: insights from molecular studies. Semin Cell Dev. Biol. 2012;23(4):421-8. doi: 10.1016/j.semcdb.2012.01.009
  8. Wang XP., Zhou J., Han M., Chen CB., Zheng YT., He XS., Yuan XP. MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway. Oncotarget. 2017;8(8):13264-76. doi: 10.18632/oncotarget.14807
  9. Zhang Y, Li D, Feng F, An L, Hui F, Dang D, Zhao Q. Progressive and prognosis value of Notch receptors and ligands in hepatocellular carcinoma: a systematic review and meta-analysis. Sci. Rep. 2017;7(1):14809. doi: 10.1038/s41598-017-14897-6
  10. Mao Y, Tang S, Yang L, Li K. Inhibition of the Notch signaling pathway reduces the differentiation of hepatic progenitor cells into cholangiocytes in biliary atresia. Cell Physiol. Biochem. 2018;49(3):1074-82. doi: 10.1159/000493290
  11. Chen Y, Zheng S, Qi D, Zheng S, Guo J, Zhang S, Weng Z. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One. 2012;7(10):e46512. doi: 10.1371/journal.pone.0046512
  12. Morell CM, Fiorotto R, Meroni M, Raizner A, Torsello B, Cadamuro M, Spagnuolo G, Kaffe E, Sutti S, Albano E, Strazzabosco M. Notch signaling and progenitor/ductular reaction in steatohepatitis. PLoS One. 2017;12(11):e0187384. doi: 10.1371/journal.pone.0187384
  13. Nijjar SS, Wallace L, Crosby HA, Hubscher SG, Strain AJ. Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am. J. Pathol. 2002;160(5):1695-703.
  14. Gilbert M.A., Spinner N.B. Alagille syndrome: Genetics and Functional Models. Curr. Pathobiol. Rep. 2017;5:233-41. doi: 10.1007/s40139-017-0144-8
  15. Lee SJ, Kim KH, Pak SC, Kang YN, Yoon GS, Park KK. Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease. Int. J. Clin. Exp. Pathol. 2015;8(10):12688-97
  16. Vanderpool C, Sparks EE, Huppert KA, Gannon M, Means AL, Huppert SS. Genetic interactions between hepatocyte nuclear factor-6 and Notch signaling regulate mouse intrahepatic bile duct development in vivo. Hepatology. 2012;55(1):233-43. doi: 10.1002/hep.24631
  17. Banerjee D, Hernandez SL, Garcia A, Kangsamaksin T, Sbiroli E, Andrews J, Forrester LA, Wei N, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Res. 2015;75(8):1592-602. doi: 10.1158/0008-5472.CAN-14-1493
  18. Geisler F, Strazzabosco M. Emerging roles of Notch signaling in liver disease. Hepatology. 2015;61(1):382-92. doi: 10.1002/hep.27268
  19. He W, Dai C. Key fibrogenic signaling. Curr. Pathobiol. Rep. 2015;3(2):183-92.
  20. Hu B, Phan SH. Notch in fibrosis and as a target of anti-fibrotic therapy. Pharmacol. Res. 2016;108:57-64. doi: 10.1016/j.phrs.2016.04.010
  21. Zhang K, Zhang YQ, Ai WB, Hu QT, Zhang QJ, Wan LY, Wang XL, Liu CB, Wu JF. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling. World J. Gastroenterol. 2015;21(3):878-87. doi: 10.3748/wjg.v21.i3.878
  22. Liu C, Liu L, Chen X, Cheng J, Zhang H, Zhang C, Shan J, Shen J, Qian C. LSD1 stimulates cancer-associated fibroblasts to drive Notch3-dependent self-renewal of livercancer stem-like cells. Cancer Res. 2018;78(4):938-49. doi: 10.1158/0008-5472.CAN-17-1236
  23. Scholten D, Osterreicher CH, Scholten A, Iwaisako K, Gu G, Brenner DA, Kisseleva T. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology. 2010;139(3):987-98. doi: 10.1053/j.gastro.2010.05.005
  24. Li H, Sun S, Lei Q, Lei P, Cai X, Wan C, Shen G. M1-polarized macrophages promote self-renewing phenotype of hepatic progenitor cells with Jagged1-Notch signalling involved: relevance in primary sclerosing cholangitis. J. Immunol. Res. 2018;4807145. doi: 10.1155/2018/4807145
  25. Terada M, Horisawa K, Miura S, Takashima Y, Ohkawa Y, Sekiya S, Matsuda-Ito K, Suzuki A. Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma. Sci. Rep. 2016;6:34691. doi: 10.1038/srep34691
  26. Bansal R, van Baarlen J, Storm G, Prakash J. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis. Sci. Rep. 2015;5:18272. doi: 10.1038/srep18272
  27. Xu J, Chi F, Tsukamoto H. Notch signaling and M1 macrophage activation in obesity-alcohol synergism. Clin. Res. Hepatol. Gastroenterol. 2015;39(1):24-8. doi: 10.1016/j.clinre.2015.05.016
  28. Morrow D, Hatch E, Hamm K, Cahill PA, Redmond EM. Flk-1/KDR mediates ethanol-stimulated endothelial cell Notch signaling and angiogenic activity. J. Vasc. Res. 2014;51(4):315-24. doi: 10.1159/000367807
  29. Urbanek K, Lesiak M, Krakowian D, Koryciak-Komarska H, Likus W, Czekaj P, Kusz D, Sieroń AL. Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts. Lab. Invest. 2017;97(10):1225-34. doi: 10.1038/labinvest.2017.60
  30. Hao X, Li Y, Wang J, Ma J, Zhao S, Ye X, He L, Yang J, Gao M, Xiao F, Wei H. Deficient O-GlcNAc glycosylation impairs regulatory Т cell differentiation and Notch signalingin autoimmune hepatitis. Front Immunol. 2018;9:2089. doi: 10.3389/fimmu.2018.02089
  31. Duan JL, Ruan B, Yan XC, Liang L, Song P, Yang ZY, Liu Y, Dou KF, Han H, Wang L. Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice. Hepatology. 2018;68(2):677-90. doi: 10.1002/hep.29834
  32. Giovannini C, Bolondi L, Gramantieri L. Targeting Notch3 in hepatocellular carcinoma: molecular mechanisms and therapeutic perspectives. Int. J. Mol. Sci. 2016;18(1). pii: E56. doi: 10.3390/ijms18010056
  33. Lin IY, Chiou YS, Wu LC, Tsai CY, Chen CT, Chuang WC, Lee MC, Lin CC, Lin TT, Chen SC, Pan MH, Ma N. CCM111 prevents hepatic fibrosis via cooperative inhibition of TGF-β, Wnt and STAT3 signaling pathways. J. Food Drug. Anal. 2019;27(1):184-94. doi: 10.1016/j.jfda.2018.09.008
  34. Genz B, Coleman MA, Irvine KM, Kutasovic JR, Miranda M, Gratte FD, Tirnitz-Parker JEE, Olynyk JK, Calvopina DA, Weis A, Cloonan N, Robinson H, Hill MM, Al-Ejeh F, Ramm GA. Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells. Sci. Rep. 2019;9(1):8541. doi: 10.1038/s41598-019-44865-1
  35. Liu C, Cheng X, Chen J, Wang Y, Wu X, Tian R, Liu B, Ding X, Sun Q, Gong W. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration. Theranostics. 2019;9(13):3840-52. doi: 10.7150/thno.33370
  36. Wu N, Nguyen Q, Wan Y, Zhou T, Venter J, Frampton GA, DeMorrow S, Pan D, Meng F, Glaser S, Alpini G, Bai H. The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammals. Lab. Invest. 2017;97(7):843-53. doi: 10.1038/labinvest.2017.29
  37. Kim W, Khan SK, Yang Y. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation. BMB Rep. 2017;50(1):1-2.
  38. Giovannini C, Bolondi L, Gramantieri L. Targeting Notch3 in hepatocellular carcinoma: molecular mechanisms and therapeutic perspectives. Int. J. Mol. Sci. 2016;18(1). pii: E56. doi: 10.3390/ijms18010056
  39. Zhou SJ, Deng YL, Liang HF, Jaoude JC, Liu FY. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signalingin hepatocellular carcinoma. Cell Death Differ. 2017;24(9):1577-87. doi: 10.1038/cdd.2017.87
  40. Jiang L, Ke M, Yue S, Xiao W, Yan Y, Deng X, Ying QL, Li J, Ke B. Blockade of Notch signaling promotes acetaminophen-induced liver injury. Immunol. Res. 2017;65(3):739-49. doi: 10.1007/s12026-017-8913-3
  41. Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One. 2012;7(11):e50826. doi: 10.1371/journal.pone.0050826
  42. Ren K, Li T, Zhang W, Ren J, Li Z, Wu G. MiR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma. J. Biomed. Sci. 2016;23(1):79.
  43. Kaylan KB, Berg IC, Biehl MJ, Brougham-Cook A, Jain I, Jamil SM, Sargeant LH, Cornell NJ, Raetzman LT, Underhill GH. Spatial patterning of liver progenitor cell differentiation mediated by cellular contractility and Notch signaling. Elife. 2018;7. pii: e38536. doi: 10.7554/eLife.38536
  44. Luo H, Liu WH, Liang HY, Yan HT, Lin N, Li DY, Wang T, Tang LJ. Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET. Oncotarget. 2018;9(27):18885 95. doi: 10.18632/oncotarget.24421
  45. Liu XB, Lo CM, Cheng Q, Ng KT, Shao Y, Li CX, Chung SK, Ng IOL, Yu J, Man K. Oval cells contribute to fibrogenesis of marginal liver grafts under stepwise regulation of aldose reductase and Notch signaling. Theranostics. 2017;7(19):4879-93. doi: 10.7150/thno.20085
  46. Wu CX, Xu A, Zhang CC, Olson P, Chen L, Lee TK, Cheung TT, Lo CM, Wang XQ. Notch inhibitor PF-03084014 inhibits hepatocellular carcinoma growth and metastasis via suppression of cancer stemness due to reduced activation of Notch1-Stat3. Mol. Cancer. Ther. 2017;16(8):1531-43. doi: 10.1158/1535-7163.MCT-17-0001
  47. Lu J, Xia Y, Chen K, Zheng Y, Wang J, Lu W, Yin Q, Wang F, Zhou Y, Guo C. Oncogenic role of the Notch pathway in primary liver cancer. Oncol. Lett. 2016;12(1):3-10.
  48. Gu Y, Xiao L, Ming Y, Zheng Z, Li W. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo. Int. J. Oncol. 2016;48(5):1868-76. doi: 10.3892/ijo.2016.3413

Downloads

How to Cite

Lebedeva, E. I. (2020). The role of the Notch signaling pathway in liver fibrogenesis. Морфологія / Morphologia / Morfologìâ, 14(1), 7–15. https://doi.org/10.26641/1997-9665.2020.1.7-15

Issue

Vol. 14 No. 1 (2020)

Section

Статті

License

Copyright (c) 2020 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.